98 related articles for article (PubMed ID: 33041448)
1. Investigating Cervical Risk Factors that Lead to Cytological and Biopsy Examination.
Sindiani AM; Alshdaifat EH; Alkhatib AJ
Med Arch; 2020 Aug; 74(4):294-297. PubMed ID: 33041448
[TBL] [Abstract][Full Text] [Related]
2. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
3. Can women at risk of cervical abnormality be identified?
Blomfield PI; Lancashire RJ; Woodman CB
Br J Obstet Gynaecol; 1998 May; 105(5):486-92. PubMed ID: 9637116
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
6. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
8. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.
Roura E; Iftner T; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; Rodriguez MS; Morillo C; Serradell L; Torcel-Pagnon L; Cortes J; Castellsagué X;
BMC Infect Dis; 2012 Jun; 12():145. PubMed ID: 22734435
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based statistical analysis for early stage detection of cervical cancer.
Ali MM; Ahmed K; Bui FM; Paul BK; Ibrahim SM; Quinn JMW; Moni MA
Comput Biol Med; 2021 Dec; 139():104985. PubMed ID: 34735942
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
11. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.
Maggwa BN; Hunter DJ; Mbugua S; Tukei P; Mati JK
AIDS; 1993 May; 7(5):733-8. PubMed ID: 8318180
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjogren's syndrome.
Cirpan T; Guliyeva A; Onder G; Terek MC; Ozsaran A; Kabasakal Y; Zekioglu O; Yucebilgin S
Eur J Gynaecol Oncol; 2007; 28(4):302-6. PubMed ID: 17713098
[TBL] [Abstract][Full Text] [Related]
13. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia.
Moscicki AB; Winkler B; Irwin CE; Schachter J
J Pediatr; 1989 Sep; 115(3):487-93. PubMed ID: 2769512
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HPV cervical infection in a family planning clinic determined by polymerase chain reaction and dot blot hybridisation.
Hallam N; Green J; Gibson P; Powis J; Bibby J
J Med Virol; 1991 Jul; 34(3):154-8. PubMed ID: 1919537
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
Roset Bahmanyar E; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H; Castellsagué X; Teixeira JC; Skinner SR; Jaisamrarn U; Limson GA; Garland SM; Szarewski A; Romanowski B; Aoki F; Schwarz TF; Poppe WA; De Carvalho NS; Harper DM; Bosch FX; Raillard A; Descamps D; Struyf F; Lehtinen M; Dubin G;
Gynecol Oncol; 2012 Dec; 127(3):440-50. PubMed ID: 22940493
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
Tay SK; Oon LL
Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
[TBL] [Abstract][Full Text] [Related]
17. [Cervical cancer screening: past--present--future].
Breitenecker G
Pathologe; 2009 Dec; 30 Suppl 2():128-35. PubMed ID: 19756616
[TBL] [Abstract][Full Text] [Related]
18. Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: implications for cervical cancer control programs and human papilloma virus immunization.
Thomas JO; Ojemakinde KO; Ajayi IO; Omigbodun AO; Fawole OI; Oladepo O
Acta Cytol; 2012; 56(3):251-8. PubMed ID: 22555526
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cervical cancer in Colombia and Spain.
Bosch FX; Muñoz N; de Sanjosé S; Izarzugaza I; Gili M; Viladiu P; Tormo MJ; Moreo P; Ascunce N; Gonzalez LC
Int J Cancer; 1992 Nov; 52(5):750-8. PubMed ID: 1330934
[TBL] [Abstract][Full Text] [Related]
20. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
